Apak-212 Instant

In cellular biology, the is a critical tumor suppressor that triggers cell cycle arrest or programmed cell death (apoptosis) in response to DNA damage. However, this process must be tightly controlled to prevent unnecessary cell death in healthy tissues.

APAK-212 refers to a synthetic, modular peptide-based construct primarily used in preclinical molecular biology and cancer research. It is specifically designed as a pharmacological tool to modulate the , a KRAB-type zinc finger protein (also known as ZNF420) that acts as a natural negative regulator of p53-mediated apoptosis. Overview of APAK (ZNF420) APAK-212

: In solid tumors, low oxygen levels (hypoxia) can lead to the epigenetic repression of APAK, which unexpectedly triggers p53-dependent apoptosis. Tools that modulate APAK help clarify these complex survival mechanisms. In cellular biology, the is a critical tumor

: It often incorporates specific domains from the natural APAK protein, such as the zinc finger motifs or the KRAB domain, to target the p53 interaction interface. It is specifically designed as a pharmacological tool

: Because APAK specifically regulates the apoptotic function of p53 without affecting its cell-cycle arrest function, it is viewed as a highly specific target for drugs aimed at sensitizing cancer cells to chemotherapy without damaging healthy, non-dividing cells.